Glucotrack (GCTK) Operating Expenses (2010 - 2026)

Glucotrack (GCTK) has reported Operating Expenses for 17 consecutive years, with $3.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses fell 29.11% year-over-year to $3.4 million; the trailing twelve-month figure through Jun 2026 stood at $16.0 million (up 3.85% YoY), and the FY2025 full-year result was $16.1 million, up 10.61% from the prior year.
• Operating Expenses fell to $3.4 million in Q2 2026 per GCTK's latest filing, from $3.5 million in the prior quarter.
• Across five years, Operating Expenses topped out at $4.8 million in Q2 2025 and bottomed at $929000.0 in Q3 2022.
• Historically, Operating Expenses has averaged $2.7 million across 5 years, with a median of $3.0 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Operating Expenses soared 280.92% in 2024, then slipped 29.11% in 2026.
• Over 5 years, Operating Expenses stood at $1.3 million in 2022, then surged by 87.8% to $2.4 million in 2023, then jumped by 59.45% to $3.9 million in 2024, then retreated by 9.52% to $3.5 million in 2025, then decreased by 2.49% to $3.4 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $3.4 million, $3.5 million, and $4.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.